A Look At Spruce Point Capital’s Short Thesis On Ametek, Inc. (AME)
Earlier today (and as speculated by ValueWalk yesterday), Spruce Point Capital released its short thesis on manufacturing conglomerate Ametek, Inc. (NYSE:AME) claiming that the company manipulates its books in a variety of ways and that the stock has a downside of 30% - 50% (down about 3% at the moment, with plenty of volatility). The report is a monster, nearly . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email firstname.lastname@example.org or click chat.